C12N 2710/14021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2710/14021 (Viruses as such) appears on 15 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 18
- Assignees
- 16
- Inventors
- 63
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 4 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- DNA impurities in a composition comprising a parvoviral virion7 Jul 2026US 12,674,211 B2uniQure IP B.V.
- Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (rAAV) in insect cell10 Mar 2026US 12,571,001 B2Genevoyager (Wuhan) Co., Ltd.
- Recombinant transition vector for increasing foreign protein expression23 May 2023US 11,655,482 B2Chungbuk National University Industry-Academic Cooperation Foundation
- DNA impurities in a composition comprising a parvoviral virion1 Jun 2021US 11,021,762 B2uniQure IP B.V.
- Nucleic acid application primers10 Nov 2020US 10,829,785 B2Trizell Ltd.
- Precision recombinant adeno-associated virus vector and use thereof25 Dec 2025US 2025/0388928 A1Suzhou Genehealth Biotechnology,Co., Ltd.
- Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (raav) in insect cell27 Feb 2025US 2025/0066814 A1Genevoyager (Wuhan) Co., Ltd.
- Recombinant baculoviruses, vaccine compositions that comprise it, and methods for inducing an immune response2 Jan 2025US 2025/0000961 A1Instituto Nacional De Tecnologia Agropecuaria
- Dna impurities in a composition comprising a parvoviral virion28 Oct 2021US 2021/0332447 A1uniQure IP B.V.
- Recombinant transition vector for increasing foreign protein expression17 Sep 2020US 2020/0291426 A1Chungbuk National Universit Industry Academic Cooperation Foundation
Most cited
By later US patents
- More virulent biotype isolated from wild-type virus6US 5,132,220 AThe United States of America as represented by the Secretary of Agriculture · 1992
- Baculoviruses, insecticidal compositions, and methods for control of invertebrates5US 6,521,454 B1The United States of America as represented by the Secretary of Agriculture · 2003
- Vectors5US 9,212,374 B2London School of Hygiene and Tropical Medicine · 2015
- Baculovirus for the control of insect pests2US 6,042,843 AThe United States of America as represented by the Secretary of Agriculture · 2000
- Microcin and uses thereof2US 9,492,500 B2Washington State University · 2016